In terms of the molecular hypothesis, we propose the differential KOR signaling as a rationale for the lack of adverse effects of oxa-noribogaine such as aversion and depression-like behaviors59–64; however, the inherited iboga polypharmacology may also contribute to the in vivo pharmacological profile of oxa-noribogaine65. Here, OPRK1 is linked to depressive disorder.